 |
|
Thomas M. Rinderknecht was born in 1954 and is a Swiss citizen. He is an attorney-at-law and senior partner at Badertscher Rechtsanwälte AG, Zurich and Zug. He has served on the Boards of Directors of several biotech, pharma and medtech companies including Speedel AG, Basel, Glycart Biotechnology AG, Schlieren, and Ganymed Pharmaceuticals AG, Mainz, Germany. He currently serves as Chairman of Canyon Pharmaceuticals AG, Zug, and Vice-Chairman of APR Applied Pharma Research SA, Balerna. Dr. Rinderknecht holds a PhD in law from the University of Zurich and is admitted to the Bar in Zurich, Switzerland. |